ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.130
+0.050 (4.63%)
At close: Oct 2, 2026, 4:00 PM EDT
1.120
-0.010 (-0.88%)
After-hours: Oct 2, 2026, 7:31 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $144.26 million as of October 2, 2026. Its market cap has decreased by -67.94% in one year.
Market Cap
144.26M
Enterprise Value
363.35M
1-Year Change
-67.94%
Ranking
Category
Stock Price
$1.13
ChartMarket Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $144.26M, a decrease of -92.94%. That is a compound annual growth rate of -33.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 144.26M | -67.01% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 252.16M |
| Lifecore Biomedical | 247.18M |
| Akebia Therapeutics | 241.36M |
| SIGA Technologies | 240.70M |
| Journey Medical | 189.67M |
| Cardiol Therapeutics | 182.82M |
| Organogenesis Holdings | 180.14M |
| Organigram Global | 138.53M |